In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Presentation at MOST® Cooperation's Interconnectivity Conference Asia 2015 Highlights the Value of Automotive Grade Linux in Creating a New Automotive Industry Landscape
New "Big Data" SEER Study Establishes Oncotype DX as the Only Multi-gene Breast Cancer Test with Industry-leading Level of Prospective Outcomes Evidence in Tens of Thousands of Patients
DBW 16 Presents Some of the Most Dynamic, Forward-Thinking Leaders Who AreShaping and Driving the Industry; Best Early-Bird Registration Rates Expire Dec. 15
Representatives from Costa Rica, Ethiopia, and the Philippines participate in a panel discussion during COP21 to discuss three steps to green finance: innovative international finance, national instruments, and bankable projects
The company's Sustainable Value Strategies and Goals promote leadership and continuous improvement, while delivering innovation in products and the ways the company works.
"See Threats Coming" Presentation Will Arm Attendees With Insight Into Incident Response And Domain-based Threat Intelligence To Defend Against Cyberattacks
- ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] is built on ADVATE [Antihemophilic Factor (Recombinant)], offering proven bleed protection with a simple, twice-weekly dosing schedule
BLINCYTO, Only Bispecific T Cell Engager (BiTE®) Immunotherapy Approved in US and EU, Shows Benefit in Phase 2 Trial in Patients With Persistent or Recurrent Minimal Residual Disease (MRD)
Phase 3 IMBRUVICA monotherapy results in mantle cell lymphoma published online in The Lancet and simultaneously presented at the 2015 American Society of Hematology (ASH) Meeting
- Venetoclax monotherapy response rates, including Complete Remissions, reported in Phase 2 study of relapsed/refractory chronic lymphocytic leukemia patients with 17p deletion
-- Findings featured in the official press program at the 57th American Society of Hematology Annual Meeting & Exposition; simultaneously published online in The New England Journal of Medicine
Frost & Sullivan will participate in the panel discussion on new regenerative cell-gene therapy at the 2015 World Stem Cell Summit - RegMed Capital Conference
Beat AML research initiative, led by the OHSU Knight Cancer Institute and The Leukemia & Lymphoma Society, expands to nine industry collaborators; results from the initiative's studies to be presented at American Society of Hematology Annual Meeting
Upgraded SaaS Telepharmacy Cloud Platform Enhances Larger Health System and IDN Ability to Optimize and Process Pharmacy Orders across Diverse Care Settings